Regorafenib tablets are a multi-kinase inhibitor ,which is used to treat various types of cancers, including colorectal cancer, gastrointestinal stromal tumors (GISTs), and hepatocellular carcinoma (HCC).

The global Regorafenib Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Regorafenib Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Regorafenib Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Regorafenib Drugs include Bayer, Natco, Kelun Pharmaceutical, Hansoh Pharma, Chia Tai Tianqing Pharmaceutical, Zhejiang Huayi Pharmaceutical, Qilu Pharmaceutical, Shanghai Acebright Pharmaceuticals, Yangtze River Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Regorafenib Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Regorafenib Drugs.

The Regorafenib Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Regorafenib Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Regorafenib Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Regorafenib Drugs Market Report

Report Metric	Details
Report Name	Regorafenib Drugs Market
Segment by Type	Original Drug Generic Drug
Segment by Application	Hepatocellular Carcinoma Metastatic Colorectal Cancer Gastrointestinal Stromal Tumors
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bayer, Natco, Kelun Pharmaceutical, Hansoh Pharma, Chia Tai Tianqing Pharmaceutical, Zhejiang Huayi Pharmaceutical, Qilu Pharmaceutical, Shanghai Acebright Pharmaceuticals, Yangtze River Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Regorafenib Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Regorafenib Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Regorafenib Drugs Market report?

Ans: The main players in the Regorafenib Drugs Market are Bayer, Natco, Kelun Pharmaceutical, Hansoh Pharma, Chia Tai Tianqing Pharmaceutical, Zhejiang Huayi Pharmaceutical, Qilu Pharmaceutical, Shanghai Acebright Pharmaceuticals, Yangtze River Pharmaceutical

What are the Application segmentation covered in the Regorafenib Drugs Market report?

Ans: The Applications covered in the Regorafenib Drugs Market report are Hepatocellular Carcinoma, Metastatic Colorectal Cancer, Gastrointestinal Stromal Tumors

What are the Type segmentation covered in the Regorafenib Drugs Market report?

Ans: The Types covered in the Regorafenib Drugs Market report are Original Drug, Generic Drug

1 Regorafenib Drugs Market Overview

1.1 Product Definition

1.2 Regorafenib Drugs by Type

1.2.1 Global Regorafenib Drugs Market Value Comparison by Type (2024-2030)

1.2.2 Original Drug

1.2.3 Generic Drug

1.3 Regorafenib Drugs by Application

1.3.1 Global Regorafenib Drugs Market Value by Application (2024-2030)

1.3.2 Hepatocellular Carcinoma

1.3.3 Metastatic Colorectal Cancer

1.3.4 Gastrointestinal Stromal Tumors

1.4 Global Regorafenib Drugs Market Size Estimates and Forecasts

1.4.1 Global Regorafenib Drugs Revenue 2019-2030

1.4.2 Global Regorafenib Drugs Sales 2019-2030

1.4.3 Global Regorafenib Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Regorafenib Drugs Market Competition by Manufacturers

2.1 Global Regorafenib Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Regorafenib Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Regorafenib Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Regorafenib Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Regorafenib Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Regorafenib Drugs, Product Type & Application

2.7 Global Key Manufacturers of Regorafenib Drugs, Date of Enter into This Industry

2.8 Global Regorafenib Drugs Market Competitive Situation and Trends

2.8.1 Global Regorafenib Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Regorafenib Drugs Players Market Share by Revenue

2.8.3 Global Regorafenib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Regorafenib Drugs Market Scenario by Region

3.1 Global Regorafenib Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Regorafenib Drugs Sales by Region: 2019-2030

3.2.1 Global Regorafenib Drugs Sales by Region: 2019-2024

3.2.2 Global Regorafenib Drugs Sales by Region: 2025-2030

3.3 Global Regorafenib Drugs Revenue by Region: 2019-2030

3.3.1 Global Regorafenib Drugs Revenue by Region: 2019-2024

3.3.2 Global Regorafenib Drugs Revenue by Region: 2025-2030

3.4 North America Regorafenib Drugs Market Facts & Figures by Country

3.4.1 North America Regorafenib Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Regorafenib Drugs Sales by Country (2019-2030)

3.4.3 North America Regorafenib Drugs Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Regorafenib Drugs Market Facts & Figures by Country

3.5.1 Europe Regorafenib Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Regorafenib Drugs Sales by Country (2019-2030)

3.5.3 Europe Regorafenib Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Regorafenib Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Regorafenib Drugs Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Regorafenib Drugs Sales by Region (2019-2030)

3.6.3 Asia Pacific Regorafenib Drugs Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Regorafenib Drugs Market Facts & Figures by Country

3.7.1 Latin America Regorafenib Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Regorafenib Drugs Sales by Country (2019-2030)

3.7.3 Latin America Regorafenib Drugs Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Regorafenib Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Regorafenib Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Regorafenib Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Regorafenib Drugs Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Regorafenib Drugs Sales by Type (2019-2030)

4.1.1 Global Regorafenib Drugs Sales by Type (2019-2024)

4.1.2 Global Regorafenib Drugs Sales by Type (2025-2030)

4.1.3 Global Regorafenib Drugs Sales Market Share by Type (2019-2030)

4.2 Global Regorafenib Drugs Revenue by Type (2019-2030)

4.2.1 Global Regorafenib Drugs Revenue by Type (2019-2024)

4.2.2 Global Regorafenib Drugs Revenue by Type (2025-2030)

4.2.3 Global Regorafenib Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Regorafenib Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Regorafenib Drugs Sales by Application (2019-2030)

5.1.1 Global Regorafenib Drugs Sales by Application (2019-2024)

5.1.2 Global Regorafenib Drugs Sales by Application (2025-2030)

5.1.3 Global Regorafenib Drugs Sales Market Share by Application (2019-2030)

5.2 Global Regorafenib Drugs Revenue by Application (2019-2030)

5.2.1 Global Regorafenib Drugs Revenue by Application (2019-2024)

5.2.2 Global Regorafenib Drugs Revenue by Application (2025-2030)

5.2.3 Global Regorafenib Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Regorafenib Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Bayer

6.1.1 Bayer Company Information

6.1.2 Bayer Description and Business Overview

6.1.3 Bayer Regorafenib Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Bayer Regorafenib Drugs Product Portfolio

6.1.5 Bayer Recent Developments/Updates

6.2 Natco

6.2.1 Natco Company Information

6.2.2 Natco Description and Business Overview

6.2.3 Natco Regorafenib Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Natco Regorafenib Drugs Product Portfolio

6.2.5 Natco Recent Developments/Updates

6.3 Kelun Pharmaceutical

6.3.1 Kelun Pharmaceutical Company Information

6.3.2 Kelun Pharmaceutical Description and Business Overview

6.3.3 Kelun Pharmaceutical Regorafenib Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Kelun Pharmaceutical Regorafenib Drugs Product Portfolio

6.3.5 Kelun Pharmaceutical Recent Developments/Updates

6.4 Hansoh Pharma

6.4.1 Hansoh Pharma Company Information

6.4.2 Hansoh Pharma Description and Business Overview

6.4.3 Hansoh Pharma Regorafenib Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Hansoh Pharma Regorafenib Drugs Product Portfolio

6.4.5 Hansoh Pharma Recent Developments/Updates

6.5 Chia Tai Tianqing Pharmaceutical

6.5.1 Chia Tai Tianqing Pharmaceutical Company Information

6.5.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview

6.5.3 Chia Tai Tianqing Pharmaceutical Regorafenib Drugs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Chia Tai Tianqing Pharmaceutical Regorafenib Drugs Product Portfolio

6.5.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates

6.6 Zhejiang Huayi Pharmaceutical

6.6.1 Zhejiang Huayi Pharmaceutical Company Information

6.6.2 Zhejiang Huayi Pharmaceutical Description and Business Overview

6.6.3 Zhejiang Huayi Pharmaceutical Regorafenib Drugs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Zhejiang Huayi Pharmaceutical Regorafenib Drugs Product Portfolio

6.6.5 Zhejiang Huayi Pharmaceutical Recent Developments/Updates

6.7 Qilu Pharmaceutical

6.7.1 Qilu Pharmaceutical Company Information

6.7.2 Qilu Pharmaceutical Description and Business Overview

6.7.3 Qilu Pharmaceutical Regorafenib Drugs Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Qilu Pharmaceutical Regorafenib Drugs Product Portfolio

6.7.5 Qilu Pharmaceutical Recent Developments/Updates

6.8 Shanghai Acebright Pharmaceuticals

6.8.1 Shanghai Acebright Pharmaceuticals Company Information

6.8.2 Shanghai Acebright Pharmaceuticals Description and Business Overview

6.8.3 Shanghai Acebright Pharmaceuticals Regorafenib Drugs Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Shanghai Acebright Pharmaceuticals Regorafenib Drugs Product Portfolio

6.8.5 Shanghai Acebright Pharmaceuticals Recent Developments/Updates

6.9 Yangtze River Pharmaceutical

6.9.1 Yangtze River Pharmaceutical Company Information

6.9.2 Yangtze River Pharmaceutical Description and Business Overview

6.9.3 Yangtze River Pharmaceutical Regorafenib Drugs Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Yangtze River Pharmaceutical Regorafenib Drugs Product Portfolio

6.9.5 Yangtze River Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Regorafenib Drugs Industry Chain Analysis

7.2 Regorafenib Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Regorafenib Drugs Production Mode & Process

7.4 Regorafenib Drugs Sales and Marketing

7.4.1 Regorafenib Drugs Sales Channels

7.4.2 Regorafenib Drugs Distributors

7.5 Regorafenib Drugs Customers

8 Regorafenib Drugs Market Dynamics

8.1 Regorafenib Drugs Industry Trends

8.2 Regorafenib Drugs Market Drivers

8.3 Regorafenib Drugs Market Challenges

8.4 Regorafenib Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Chia Tai-Tianqing Pharmaceutical

Qilu Pharmaceutical

Shanghai Acebright Pharmaceuticals

Yangtze River Pharmaceutical

Zhejiang Huayi Pharmaceutical

List of Tables

Table 1. Global Regorafenib Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Regorafenib Drugs Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Regorafenib Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Regorafenib Drugs Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Regorafenib Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Regorafenib Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Regorafenib Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Regorafenib Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Regorafenib Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Regorafenib Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Regorafenib Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Regorafenib Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Regorafenib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regorafenib Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Regorafenib Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Regorafenib Drugs Sales by Region (2019-2024) & (K Units)

Table 18. Global Regorafenib Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Regorafenib Drugs Sales by Region (2025-2030) & (K Units)

Table 20. Global Regorafenib Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Regorafenib Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Regorafenib Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Regorafenib Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Regorafenib Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Regorafenib Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Regorafenib Drugs Sales by Country (2019-2024) & (K Units)

Table 27. North America Regorafenib Drugs Sales by Country (2025-2030) & (K Units)

Table 28. North America Regorafenib Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Regorafenib Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Regorafenib Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Regorafenib Drugs Sales by Country (2019-2024) & (K Units)

Table 32. Europe Regorafenib Drugs Sales by Country (2025-2030) & (K Units)

Table 33. Europe Regorafenib Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Regorafenib Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Regorafenib Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Regorafenib Drugs Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Regorafenib Drugs Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Regorafenib Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Regorafenib Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Regorafenib Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Regorafenib Drugs Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Regorafenib Drugs Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Regorafenib Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Regorafenib Drugs Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Regorafenib Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Regorafenib Drugs Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Regorafenib Drugs Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Regorafenib Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Regorafenib Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Regorafenib Drugs Sales (K Units) by Type (2019-2024)

Table 51. Global Regorafenib Drugs Sales (K Units) by Type (2025-2030)

Table 52. Global Regorafenib Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Regorafenib Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Regorafenib Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Regorafenib Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Regorafenib Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Regorafenib Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Regorafenib Drugs Price (US$/Unit) by Type (2019-2024)

Table 59. Global Regorafenib Drugs Price (US$/Unit) by Type (2025-2030)

Table 60. Global Regorafenib Drugs Sales (K Units) by Application (2019-2024)

Table 61. Global Regorafenib Drugs Sales (K Units) by Application (2025-2030)

Table 62. Global Regorafenib Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Regorafenib Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Regorafenib Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Regorafenib Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Regorafenib Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Regorafenib Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Regorafenib Drugs Price (US$/Unit) by Application (2019-2024)

Table 69. Global Regorafenib Drugs Price (US$/Unit) by Application (2025-2030)

Table 70. Bayer Company Information

Table 71. Bayer Description and Business Overview

Table 72. Bayer Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Bayer Regorafenib Drugs Product

Table 74. Bayer Recent Developments/Updates

Table 75. Natco Company Information

Table 76. Natco Description and Business Overview

Table 77. Natco Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Natco Regorafenib Drugs Product

Table 79. Natco Recent Developments/Updates

Table 80. Kelun Pharmaceutical Company Information

Table 81. Kelun Pharmaceutical Description and Business Overview

Table 82. Kelun Pharmaceutical Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Kelun Pharmaceutical Regorafenib Drugs Product

Table 84. Kelun Pharmaceutical Recent Developments/Updates

Table 85. Hansoh Pharma Company Information

Table 86. Hansoh Pharma Description and Business Overview

Table 87. Hansoh Pharma Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Hansoh Pharma Regorafenib Drugs Product

Table 89. Hansoh Pharma Recent Developments/Updates

Table 90. Chia Tai Tianqing Pharmaceutical Company Information

Table 91. Chia Tai Tianqing Pharmaceutical Description and Business Overview

Table 92. Chia Tai Tianqing Pharmaceutical Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Chia Tai Tianqing Pharmaceutical Regorafenib Drugs Product

Table 94. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates

Table 95. Zhejiang Huayi Pharmaceutical Company Information

Table 96. Zhejiang Huayi Pharmaceutical Description and Business Overview

Table 97. Zhejiang Huayi Pharmaceutical Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Zhejiang Huayi Pharmaceutical Regorafenib Drugs Product

Table 99. Zhejiang Huayi Pharmaceutical Recent Developments/Updates

Table 100. Qilu Pharmaceutical Company Information

Table 101. Qilu Pharmaceutical Description and Business Overview

Table 102. Qilu Pharmaceutical Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Qilu Pharmaceutical Regorafenib Drugs Product

Table 104. Qilu Pharmaceutical Recent Developments/Updates

Table 105. Shanghai Acebright Pharmaceuticals Company Information

Table 106. Shanghai Acebright Pharmaceuticals Description and Business Overview

Table 107. Shanghai Acebright Pharmaceuticals Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Shanghai Acebright Pharmaceuticals Regorafenib Drugs Product

Table 109. Shanghai Acebright Pharmaceuticals Recent Developments/Updates

Table 110. Yangtze River Pharmaceutical Company Information

Table 111. Yangtze River Pharmaceutical Description and Business Overview

Table 112. Yangtze River Pharmaceutical Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Yangtze River Pharmaceutical Regorafenib Drugs Product

Table 114. Yangtze River Pharmaceutical Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Regorafenib Drugs Distributors List

Table 118. Regorafenib Drugs Customers List

Table 119. Regorafenib Drugs Market Trends

Table 120. Regorafenib Drugs Market Drivers

Table 121. Regorafenib Drugs Market Challenges

Table 122. Regorafenib Drugs Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Regorafenib Drugs

Figure 2. Global Regorafenib Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Regorafenib Drugs Market Share by Type: 2023 & 2030

Figure 4. Original Drug Product Picture

Figure 5. Generic Drug Product Picture

Figure 6. Global Regorafenib Drugs Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Regorafenib Drugs Market Share by Application: 2023 & 2030

Figure 8. Hepatocellular Carcinoma

Figure 9. Metastatic Colorectal Cancer

Figure 10. Gastrointestinal Stromal Tumors

Figure 11. Global Regorafenib Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Regorafenib Drugs Market Size (2019-2030) & (US$ Million)

Figure 13. Global Regorafenib Drugs Sales (2019-2030) & (K Units)

Figure 14. Global Regorafenib Drugs Average Price (US$/Unit) & (2019-2030)

Figure 15. Regorafenib Drugs Report Years Considered

Figure 16. Regorafenib Drugs Sales Share by Manufacturers in 2023

Figure 17. Global Regorafenib Drugs Revenue Share by Manufacturers in 2023

Figure 18. Global 5 and 10 Largest Regorafenib Drugs Players: Market Share by Revenue in Regorafenib Drugs in 2023

Figure 19. Regorafenib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 20. Global Regorafenib Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Regorafenib Drugs Sales Market Share by Country (2019-2030)

Figure 22. North America Regorafenib Drugs Revenue Market Share by Country (2019-2030)

Figure 23. United States Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Regorafenib Drugs Sales Market Share by Country (2019-2030)

Figure 26. Europe Regorafenib Drugs Revenue Market Share by Country (2019-2030)

Figure 27. Germany Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Regorafenib Drugs Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Regorafenib Drugs Revenue Market Share by Region (2019-2030)

Figure 34. China Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Regorafenib Drugs Sales Market Share by Country (2019-2030)

Figure 42. Mexico Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East and Africa Regorafenib Drugs Sales Market Share by Country (2019-2030)

Figure 47. Middle East and Africa Regorafenib Drugs Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Regorafenib Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Regorafenib Drugs by Type (2019-2030)

Figure 52. Global Revenue Market Share of Regorafenib Drugs by Type (2019-2030)

Figure 53. Global Regorafenib Drugs Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Regorafenib Drugs by Application (2019-2030)

Figure 55. Global Revenue Market Share of Regorafenib Drugs by Application (2019-2030)

Figure 56. Global Regorafenib Drugs Price (US$/Unit) by Application (2019-2030)

Figure 57. Regorafenib Drugs Value Chain

Figure 58. Regorafenib Drugs Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions